{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:29:21Z","timestamp":1792189761295,"version":"4.4.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the changes in the cortical thickness of the region of interest (ROI) and plasma A\u03b240, A\u03b242, and phosphorylated Tau (P-Tau) concentrations in patients with Alzheimer\u2019s disease (AD) and amnestic mild cognitive impairment (aMCI) as the disease progressed with surface-based morphometry (SBM), to analyze the correlation between ROI cortical thickness and measured plasma indexes and neuropsychological scales, and to explore the clinical value of ROI cortical thickness combined with plasma A\u03b240, A\u03b242, and P-Tau in the early recognition and diagnosis of AD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study enrolled 33 patients with AD, 48 patients with aMCI, and 33 healthy controls (normal control, NC). Concentration changes in plasma A\u03b242, A\u03b240, and P-Tau collected in each group were analyzed. Meanwhile, the whole brain T1 structure images (T1WI-3D-MPRAGE) of each group of patients were collected, and T1 image in AD-aMCI, AD-NC, and aMCI-NC group were analyzed and processed by SBM technology to obtain brain regions with statistical differences as clusters, and the cortical thickness of each cluster was extracted. Multivariate ordered logistic regression analysis was used to screen out the measured plasma indexes and the indexes with independent risk factors in the cortical thickness of each cluster. Three comparative receiver operating characteristic (ROC) curves of AD-aMCI, AD-NC, and aMCI-NC groups were plotted, respectively, to explore the diagnostic value of multi-factor combined prediction for cognitive impairment. The relationship between cortical thickness and plasma indexes, and between cortical thickness and Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scores were clarified by Pearson correlation analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Plasma A\u03b240, A\u03b242, and P-Tau proteins in the NC, aMCI, and AD groups increased with the progression of AD (<jats:italic>P<\/jats:italic> &amp;lt; 0.01); cortical thickness reductions in the AD-aMCI groups and AD-NC groups mainly involved the bilateral superior temporal gyrus, transverse temporal gyrus, superior marginal gyrus, insula, right entorhinal cortex, right fusiform gyrus, and cingulate gyrus. However, there were no statistical significances in cortical thickness reductions in the aMCI and NC groups. The cortical thickness of the ROI was negatively correlated with plasma A\u03b240, A\u03b242, and P-Tau concentrations (<jats:italic>P<\/jats:italic> &amp;lt; 0.05), and the cortical thickness of the ROI was positively correlated with MMSE and MoCA scores. Independent risk factors such as A\u03b240, A\u03b242, P-Tau, and AD-NC cluster 1R (right superior temporal gyrus, temporal pole, entorhinal cortex, transverse temporal gyrus, fusiform gyrus, superior marginal gyrus, middle temporal gyrus, and inferior temporal gyrus) were combined to plot ROC curves. The diagnostic efficiency of plasma indexes was higher than that of cortical thickness indexes, the diagnostic efficiency of ROC curves after the combination of cortical thickness and plasma indexes was higher than that of cortical thickness or plasma indexes alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma A\u03b240, A\u03b242, and P-Tau may be potential biomarkers for early prediction of AD. As the disease progressed, AD patients developed cortical atrophy characterized by atrophy of the medial temporal lobe. The combined prediction of these region and plasma A\u03b240, A\u03b242, and P-Tau had a higher diagnostic value than single-factor prediction for cognitive decline.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.816043","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T12:45:08Z","timestamp":1650890708000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Correlation Between Brain Structure Atrophy and Plasma Amyloid-\u03b2 and Phosphorylated Tau in Patients With Alzheimer\u2019s Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry"],"prefix":"10.3389","volume":"14","author":[{"given":"Kaidi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1093\/brain\/aww083","article-title":"Thalamic pathology and memory loss in early Alzheimer\u2019s disease: moving the focus from the medial temporal lobe to Papez circuit.","volume":"139","author":"Aggleton","year":"2016","journal-title":"Brain"},{"key":"B2","author":"Arthur","year":"2001","journal-title":"Diagnostic and statistical manual of mental disorders (4th ed) and text revision."},{"key":"B3","first-page":"637","article-title":"Clinical dementia rating (CDR).","volume":"24","author":"Berg","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"B4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/jad-190533","article-title":"Ultrasensitive detection of plasma Amyloid-\u03b2 as a biomarker for cognitively normal elderly individuals at risk of alzheimer\u2019s disease.","volume":"71","author":"Chatterjee","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50315-9","article-title":"Plasma A\u03b242 and total tau predict cognitive decline in amnestic mild cognitive impairment.","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease.","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neuroimage.2012.09.050","article-title":"Cortical thickness and central surface estimation.","volume":"65","author":"Dahnke","year":"2013","journal-title":"Neuroimage"},{"key":"B8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"key":"B9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0518-8","article-title":"Tau and atrophy: domain-specific relationships with cognition.","volume":"11","author":"Digma","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/s1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria.","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/s1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria.","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in alzheimer\u2019s disease: mechanisms and therapeutic strategies.","volume":"15","author":"Gao","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222446","article-title":"Early diagnosis of Alzheimer\u2019s disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images.","volume":"14","author":"Gupta","year":"2019","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/alz.12249","article-title":"Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults.","volume":"17","author":"Harrison","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/YCO.0b013e3280ebb613","article-title":"Magnetic resonance analysis of amygdalar volume in Alzheimer\u2019s disease.","volume":"20","author":"Hor\u00ednek","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05390-1","article-title":"Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer\u2019s disease.","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet. Neurol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease.","volume":"4","author":"Liu","year":"2019","journal-title":"Signal. Transduct. Target Ther."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00226","article-title":"Plasma Levels of A\u03b242 and tau identified probable alzheimer\u2019s dementia: findings in two cohorts.","volume":"9","author":"Lue","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/jneurosci.2028-17.2017","article-title":"Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging.","volume":"38","author":"Maass","year":"2018","journal-title":"J. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00401-017-1740-8","article-title":"[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.","volume":"134","author":"Marqui\u00e9","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101837","article-title":"Prediction of Alzheimer\u2019s disease dementia with MRI beyond the short-term: Implications for the design of predictive models.","volume":"23","author":"Moscoso","year":"2019","journal-title":"Neuroim. Clin."},{"key":"B29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease.","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1212\/wnl.0000000000006875","article-title":"Associations between tau, A\u03b2, and cortical thickness with cognition in Alzheimer disease.","volume":"92","author":"Ossenkoppele","year":"2019","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease.","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","article-title":"Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer\u2019s disease.","volume":"58","author":"Pereira","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity.","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome.","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11682-016-9581-y","article-title":"Cognitive reserve and cortical thickness in preclinical Alzheimer\u2019s disease.","volume":"11","author":"Pettigrew","year":"2017","journal-title":"Brain Imag. Behav."},{"key":"B37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nicl.2016.06.010","article-title":"Cortical thickness in relation to clinical symptom onset in preclinical AD.","volume":"12","author":"Pettigrew","year":"2016","journal-title":"Neuroimag. Clin."},{"key":"B38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/jnnp.2005.085332","article-title":"Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer\u2019s Disease.","volume":"77","author":"Portet","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.dadm.2018.02.007","article-title":"The personalized Alzheimer\u2019s disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment.","volume":"10","author":"Racine","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neuroimage.2017.06.072","article-title":"Joint prediction of multiple scores captures better individual traits from brain images.","volume":"158","author":"Rahim","year":"2017","journal-title":"Neuroimage"},{"key":"B41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.dadm.2019.05.007","article-title":"Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.","volume":"11","author":"Risacher","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/archneurol.2011.167","article-title":"The dynamics of cortical and hippocampal atrophy in Alzheimer disease.","volume":"68","author":"Sabuncu","year":"2011","journal-title":"Arch. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.neuroimage.2010.09.088","article-title":"Adjusting the effect of nonstationarity in cluster-based and TFCE inference.","volume":"54","author":"Salimi-Khorshidi","year":"2011","journal-title":"Neuroimage"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/wnl.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis.","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s1474-4422(19)30480-6","article-title":"A resurrection of aducanumab for Alzheimer\u2019s disease.","volume":"19","author":"Schneider","year":"2020","journal-title":"Lancet Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease.","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12104","article-title":"Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer\u2019s disease pathology and clinical progression in older adults without dementia.","volume":"12","author":"Shen","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B48","first-page":"1","article-title":"The limbic system. An overview of the anatomy and its development.","volume":"7","author":"Sitoh","year":"1997","journal-title":"Neuroimag. Clin. N. Am."},{"key":"B49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B50","doi-asserted-by":"publisher","first-page":"10000","DOI":"10.18632\/aging.102362","article-title":"Mapping the patterns of cortical thickness in single- and multiple-domain amnestic mild cognitive impairment patients: a pilot study.","volume":"11","author":"Sun","year":"2019","journal-title":"Aging"},{"key":"B51","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-150262","article-title":"APOE Affects the volume and shape of the amygdala and the hippocampus in mild cognitive impairment and alzheimer\u2019s disease: age matters.","volume":"47","author":"Tang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease.","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3233\/jad-170784","article-title":"Plasma Amyloid-\u03b2 (A\u03b242) Correlates with Cerebrospinal Fluid A\u03b242 in Alzheimer\u2019s Disease.","volume":"62","author":"Teunissen","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1212\/wnl.0000000000001401","article-title":"Spatially distinct atrophy is linked to \u03b2-amyloid and tau in preclinical Alzheimer disease.","volume":"84","author":"Wang","year":"2015","journal-title":"Neurology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.neuroimage.2019.01.070","article-title":"When less is more: Structural correlates of core executive functions in young adults - A VBM and cortical thickness study.","volume":"189","author":"Weise","year":"2019","journal-title":"Neuroimage"},{"key":"B56","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","article-title":"Clearance of amyloid beta and tau in alzheimer\u2019s disease: from mechanisms to therapy.","volume":"34","author":"Xin","year":"2018","journal-title":"Neurotox. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","article-title":"Assay of plasma phosphorylated tau protein (Threonine 181) and total tau protein in early-stage alzheimer\u2019s disease.","volume":"61","author":"Yang","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2018.06.006","article-title":"Plasma \u03b2-amyloid(1-42) reference values in cognitively normal subjects.","volume":"391","author":"Zecca","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1515\/bmt-2016-0239","article-title":"Analysis of structural brain MRI and multi-parameter classification for Alzheimer\u2019s disease.","volume":"63","author":"Zhang","year":"2018","journal-title":"Biomed. Tech."},{"key":"B60","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/1567205012666150530202729","article-title":"Auditory verbal learning test is superior to rey-osterrieth complex figure memory for predicting mild cognitive impairment to alzheimer\u2019s disease.","volume":"12","author":"Zhao","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10030085","article-title":"Current biomarkers for alzheimer\u2019s disease: from CSF to Blood.","volume":"10","author":"Zou","year":"2020","journal-title":"J. Pers. Med."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.816043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T12:45:16Z","timestamp":1650890716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.816043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":61,"alternative-id":["10.3389\/fnagi.2022.816043"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.816043","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"816043"}}